Evidence map›Paper›PMID 38883353›Full record

ReviewAmerican journal of translational research2024

Therapeutic and pharmacological efficacy of plant-derived bioactive compounds in targeting breast cancer.

Heena Saini, Partha Basu, Tanuja Nesari, Vitthal Govindappa Huddar, Koninika Ray, Anil Srivastava, Subhash Gupta, Ravi Mehrotra, Richa Tripathi

Abstract readReview
In one paragraph

Review in American journal of translational research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. [Erianin inhibits proliferation and migration of breast cancer cellsNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Heena SainiIntegrated Translational Molecular Biology Unit (ITMBU), Department of Rog Nidan evam Vikriti Vigyan (Pathology), All India Institute of Ayurveda New Delhi-110076, India.
Partha BasuSection of Early Detection and Prevention, International Agency for Research on Cancer Lyon-69008, France.
Tanuja NesariDepartment of Dravyaguna (Materia Medica and Pharmacology), All India Institute of Ayurveda New Delhi-110076, India.
Vitthal Govindappa HuddarDepartment of Kayachikitsa (Internal Medicine), All India Institute of Ayurveda New Delhi-110076, India.
Koninika RayOpen Health Systems Laboratory (OHSL) Los Gatos, California-95032, US.
Anil SrivastavaOpen Health Systems Laboratory (OHSL) Los Gatos, California-95032, US.
Subhash GuptaDepartment of Radiation Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences New Delhi-110029, India.
Ravi MehrotraRollins School of Public Health, Emory University Atlanta, Georgia-30322, US.
Richa TripathiIntegrated Translational Molecular Biology Unit (ITMBU), Department of Rog Nidan evam Vikriti Vigyan (Pathology), All India Institute of Ayurveda New Delhi-110076, India.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Breast cancer (BC) ranks number one among cancers affecting women globally. Serious concerns include delayed diagnosis, poor prognosis, and adverse side effects of conventional treatment, leading to residual morbidity. Therefore, an alternative treatment approach that is safe and effective has become the need of the hour. In this regard, plant-based medicines via a combination of conventional drugs are gaining increasing acceptance worldwide, playing a pivotal role in cancer management as proven by their efficacy evaluation studies. This review aims to fill the knowledge gaps by providing the preclinical evidence of cellular and molecular mechanisms of Indian phytomedicines in targeting varied pathways of breast cancer progression. A comprehensive search was performed on different platforms, followed by screening of relevant studies for review. In this article, the in-depth of various botanical drugs covering their nomenclature, dosage, toxicity, and modus operandi in BC cells have been extensively discussed. Various signaling pathways like Notch signaling, MAPK signaling, apoptosis, Wnt signaling, etc. regulated by herbal medicine treatment in BC are also highlighted to understand the drug mechanism better. This will guide the researchers to plan future strategies and generate more robust integrated evidence of plant-based drugs or botanical formulations for their potential role in the management of BC.

Indexed as

anticancerbreast cancercancer treatmentIndian herbsintegrative oncologyPhytomedicine

Identifiers

PMID38883353
PMCPMC11170612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.